NCT01606878 2024-01-05Crizotinib and Combination Chemotherapy in Treating Younger Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell LymphomaChildren's Oncology GroupPhase 1 Completed46 enrolled 24 charts
NCT01524926 2023-12-11CREATEEuropean Organisation for Research and Treatment of Cancer - EORTCPhase 2 Completed582 enrolled
NCT00939770 2020-06-09Crizotinib in Treating Younger Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell LymphomaChildren's Oncology GroupPhase 1/2 Completed122 enrolled 24 charts 2 FDA